Non-Hodgkins Lymphoma Clinical Trials

64 clinical trials for Non-Hodgkins Lymphoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment — RECRUITING
• Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) — RECRUITING · PHASE2
• Biology Studies of Hematologic Cancers — RECRUITING
• A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL — RECRUITING · PHASE2
• An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) — ACTIVE_NOT_RECRUITING · PHASE1
• Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies — COMPLETED · PHASE1
• Resiliency in Older Adults Undergoing Bone Marrow Transplant — COMPLETED
• Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL — TERMINATED · PHASE1
• Treatment and Natural History Study of Lymphomatoid Granulomatosis — COMPLETED · PHASE2
• Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma — COMPLETED · PHASE2
• (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). — WITHDRAWN · PHASE1
• Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma — TERMINATED · PHASE1
• Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma — TERMINATED · PHASE1
• Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant — COMPLETED · PHASE2
• CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma — COMPLETED · NA
• Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma — COMPLETED · PHASE1
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning — COMPLETED · PHASE2
• Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies — TERMINATED · PHASE1
• Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. — COMPLETED · PHASE2
• Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma — COMPLETED · PHASE1
• Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies — TERMINATED · PHASE1
• Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma — COMPLETED · PHASE2
• Safety Study of NHL With 90Y-hLL2 IgG — COMPLETED · PHASE1
• Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma — TERMINATED · PHASE1
• Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies — COMPLETED · NA
• Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL — COMPLETED · PHASE1
• TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation — TERMINATED · PHASE1
• T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts — COMPLETED · PHASE2
• Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders — TERMINATED · PHASE1
• Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma — COMPLETED · PHASE2
• A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer — COMPLETED · PHASE1
• Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor — TERMINATED · NA
• Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation — TERMINATED
• Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma — TERMINATED · PHASE2
• Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma — TERMINATED · PHASE2
• 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma — COMPLETED · PHASE1
• Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies — TERMINATED · PHASE2
• A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma — COMPLETED · PHASE1
• Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment — COMPLETED · NA
• Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma — COMPLETED · PHASE2
• Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma — COMPLETED · PHASE1
• A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs — TERMINATED · PHASE2
• The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients — COMPLETED · NA
• Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL) — COMPLETED · PHASE2
• Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease — COMPLETED · PHASE1
• Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma — TERMINATED · PHASE1
• Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant — COMPLETED · PHASE2
• Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match — TERMINATED · PHASE2
• Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies — COMPLETED · PHASE1

Refine this search